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collected from the sepsis patients admitted to the intensive care
unit was investigated for the ﬁrst time. The blood and faecal
samples were collected from sepsis and nonsepsis patients,
respectively. The prevalence of the tcpC and phylogroups was
conﬁrmed by gene-speciﬁc PCR. The occurrence of the tcpC in
the blood E. coli isolates from sepsis patients was signiﬁcantly
higher than the faecal isolates. The higher prevalence of blood
E. coli isolates among the pathogenic groups (B2, D) compared to
the commensal groups (A, B1) suggests tcpC as a prospective
new virulence marker for sepsis.
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p://dx.doi.org/10.1016/j.nmni.2015.05.002urinary tract infection to life-threating sepsis [1]. It is one of the
leading causes of blood infection and has the ability to trigger a
vigorous inﬂammatory response in the host, leading to sepsis.
Bacterial pathogens have virulence factors (VFs) that contribute
to their pathogenesis. Bacterial virulence is multifactorial and
thus depends on host susceptibility and microbe characteristics
[2]. The E. coli VFs can be categorized as adhesins, toxins, iron
uptake, protectins, pathogenicity-associated islands and Toll/
interleukin 1 receptor (TIR)-containing proteins [3,4]. Virulent
TIR domain-containing proteins (Tcps) have been identiﬁed in
various bacteria [5]. Bacterial Tcps in Gram-negative/positive
bacteria such as Brucella melitensis (tcpB), Paracoccus deni-
triﬁcans (PdTIR), Staphylococcus aureus and E. coli (tcpC) is known;
however, the exact mechanism of their effect has not been fully
understood [3,5,6]. In addition, there is strong evidence of the
involvement of the homologous recombination in the spread of
the bacterial tcpC virulence [6].
The Toll-like receptor (TLR) signaling domain is the TIR
domain, which is found in the cytosolic face of TLRs as well as
their adaptors. Previous studies have revealed that a diverse
range of both pathogenic and nonpathogenic microorganisms
express proteins containing TIR domains [3,7]. Tcps may play a
role in protein–protein interaction; however, in Gram-negative
bacteria, it has been shown to shut down TLR signaling [5].
Among other microbes, TIR domain contain protein (BtpB) is
known to contribute to the virulence and control of local in-
ﬂammatory responses in the establishment of chronic brucel-
losis [8]. SaTlp1 and SaTlp2 are potential VFs of S. aureus that
interact with the innate immune signaling machinery of the host
cells [7]. Previously, we have shown a role of tcpC in the urinary
tract infection pathogenesis [3]; however, its role in patho-
genesis of sepsis is unknown.
In order to investigate the prevalence of the tcpC gene in the
blood E. coli isolates of the sepsis patients under a challenging
environment, blood samples (n = 78) were collected from pa-
tients diagnosed with sepsis and admitted to the intensive care
unit (ICU) of Vardhman Mahavir Medical College (VMCC) and
Safdarjung Hospital, Delhi, India, during 2011–2013. The
randomly selected faecal samples (n = 83) were collected as a
control from patients of cardiovascular surgeries and road ac-
cidents admitted to the ICU of VMCC and Safdarjung Hospital
who were not diagnosed with sepsis. The study was approved
by the institutional ethical committee of VMCC and Safdarjung
Hospital (S.No-VMMC/SJH/Ethics/SEP-11/29).
The E. coli isolates were collected and screened by standard
procedures. The isolates were grown as lactose-positive col-
onies on MacConkey blood agar media and then subcultured in
tryptone soy broth by incubating at 37°C for 18 hours. A
portion of the broth was pooled, and genomic DNA wasEuropean Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
FIG. 1. Presence of tcpC gene in Escherichia coli isolates from sepsis
patients. Lane M, DNA ladder; lane 1, negative control; lane 2, blood
E. coli isolates; lane 3, faecal E. coli isolates; lane 4, positive control.
FIG. 2. Comparative prevalence of phylogroups between blood
(n = 78) and faecal (n = 83) Escherichia coli isolates (A) by triplex PCR.
Correlation between tcpC and the phylogroups in E. coli isolates by
gene-speciﬁc PCR method (B). p value calculated by Fisher exact test
and indicates signiﬁcance between sepsis and nonsepsis patients.
NMNI Nagarjuna et al. tcpC as virulence marker in E. coli 29isolated. PCR was performed for ampliﬁcation of the tcpC gene
of 544 bp (Fig. 1) using bacterial genomic DNA as a template
and gene-speciﬁc primers (tcpC FP: 50-GAGTGGAAG-
GAGGTTGAGGC-30 tcpC RP: 50-GCAGTGCCATTTTATC
CGCC30). All the isolates were tested with positive and nega-
tive control in duplicate. E. coli commensal strains belong to
groups A and B1, whereas extraintestinal pathogenic strains
belong to groups B2 and D. We observed no signiﬁcant dif-
ference in the prevalence of the phylogroups in the faecal E. coli
isolates, whereas the phylogroups B2 (24%) and D (45.4%)
were found to be more prevalent (p <0.001) among the blood
E. coli isolates (Fig. 2A). Individually, we did not ﬁnd any sig-
niﬁcant difference in the prevalence of the phylogroups A and
B2 in blood and faecal E. coli isolates; however, group B1 was
found to be signiﬁcantly higher in the faecal isolates (p <0.05).
Phylogroup D (45.4%) was more prevalent in the blood
(p <0.001) compared to the faecal E. coli isolates, thus
corroborating earlier observations of extraintestinal pathogenic
strains belonging to group D.
In addition to the VFs, the discrete phylogroup (A, B1, B2
and D) of E. coli is indicative of their origins from natural
populations that may become commensal or pathogenic [9].
The prevalence of tcpC in the E. coli isolates in various disease
conditions and their correlation with the phylogroups has not
been elucidated. We were interested in investigating a possible
link between the strain phylogeny and the tcpC gene among the
blood E. coli isolates of sepsis patients. For this, we performed
triplex PCR using primers speciﬁc to genes chuA and yjaA and
DNA fragment TSPE4.C2 [10]. We found that the prevalenceNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access artiof tcpC in the pathogenic group (B2 and D) was signiﬁcantly
higher (40.3%) than the commensal groups (A and B1) (9.6%)
(p <0.005) (Fig. 2B). A high prevalence of the tcpC gene among
the blood E. coli isolates compared to the faecal ones suggests a
role of tcpC in the development of sepsis.
The Tcps of Gram-negative bacteria is known to interact
with adapter proteins MyD88 and TLR4 TIR domains and
demonstrate an inhibitory effect on the TLR signaling. In
contrast, P. denitriﬁcans TIR protein (PdTIR) interacts with
MyD88 and TLR4 TIR domains without showing an inhibitory
function [11]. TlpA from Salmonella enterica inhibits activation of
the transcription factor NF-κB [12]. tcpC from E. coli and TcpB
in a range of Brucella species (B. melitensis, B. ovis and B. abortus)
inhibit NF-κB activation by direct interaction with MyD88 [13].
The exact mechanism of the action of tcpC after its interaction
with the host proteins is unknown.
Our data have shown the presence of tcpC in a signiﬁcantly
high amount in the blood E. coli isolates of the sepsis patients,lf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 7, 28–30
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30 New Microbes and New Infections, Volume 7 Number C, September 2015 NMNIindicating its possible role in disease pathogenesis [14]. A cor-
relation between the tcpC gene and the bacterial phylogroups
has been conﬁrmed by analysing the distribution of E. coli tcpC in
different phylogroups. As expected, the prevalence of the E. coli
pathogenic group (B2 and D) was signiﬁcantly higher than the
commensal group (A and B1). The high prevalence of the tcpC
gene among blood isolates from sepsis patients also indicates its
role in the development of infection and suggests that the
challenged host environment, such as the presence of catheters
or hospital-acquired infections, or even poor hygiene due to
infrequent urination of the patient leading to a high vulnera-
bility, may have altered the bacteria’s pathogenicity [15].
In summary, we report for the ﬁrst time the prevalence of
the bacterial virulence gene tcpC in blood E. coli isolates from
sepsis patients admitted to the ICU and their correlation with
E. coli phylogroups. Further studies are ongoing to understand
the mechanism of action of tcpC in an appropriate animal model
in order to envision tcpC as a target for creating treatment
strategies.Conﬂict of interestNone declared.AcknowledgementThis work was supported by a research and development grant
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